Advertisement
UK markets open in 6 hours 38 minutes

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,207.13
    +444.10 (+2.50%)
     

  • CRUDE OIL

    79.16
    +0.21 (+0.27%)
     

  • GOLD FUTURES

    2,312.00
    +2.40 (+0.10%)
     

  • DOW

    38,225.66
    +322.37 (+0.85%)
     

  • Bitcoin GBP

    47,106.04
    +611.57 (+1.32%)
     

  • CMC Crypto 200

    1,273.43
    +2.68 (+0.21%)
     

  • NASDAQ Composite

    15,840.96
    +235.48 (+1.51%)
     

  • UK FTSE All Share

    4,446.15
    +27.55 (+0.62%)
     
Money:

Best UK mortgage deals of the week

The cheapest home loans available now

Reckitt Benckiser says pharma review ongoing

Reuters - UK Focus

LONDON, Feb 12 (Reuters) - Reckitt Benckiser Group said on Wednesday the strategic review of its pharmaceuticals business was ongoing and that it would update investors over the course of the year.

The company said in October it was considering all options for the business, which could include selling it, spinning it off, or keeping it.

Regarding acquisitions, Chief Executive Rakesh Kapoor said Reckitt would continue to be active in the consumer health space, but declined to comment specifically on reports that consumer companies have approached U.S. drugmaker Merck (Dusseldorf: 6MK.DU - news) & Co about its consumer business.